I don't think you can read anything into the timing of this news release. I am hoping for the best from earnings but expecting to be disappointed, al least on the actual earnings side (I'm sure revenue growth will be excellent as always).
I think you hit it right on the button - they are still spending alot of money for their growth, however they are being alot smarter with it than in the past. I think revs will see a nice bump, and I hope they can sqweak out an operating profit.... but I think Q4 is when we can expect a profit, especially with all the moves they have made over the last Q. Q4 is when everything will come to fruition
yep... also the buy back is at $10... that means BZNE's floor is $10... or about 10% above current trading. If they thought MSLP's prospects were negative, they would have taken it all in unrestricted/non-deferred shares today.
Bingo - the potential value in this company far exceeds 'just a suplement company', they are very similar to a BIOTECH, however they arent at the mercy of the FDA, so I think its a win/win there.
Earnings are going to be exciting this week - I do think they will have a hefty amount expeses with the ARNOLD launch and ramping up production for COSTCO.
I am not anticipating 'great' numbers, but I think they will be good. The GREAT numbers will be coming in Q4 with COSTCO in full swing and the addition of Walgreens to Fitmiss will help boost that brand.